Researchers are examining the protective role that common PDE5 inhibitor medications might play during COVID-19 infection. If proven, these medications could potentially lead to milder symptoms, fewer hospitalizations, and quicker recoveries in COVID-19 patients with pre-existing heart and lung diseases.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
A study conducted by the UMN College of Veterinary Medicine found that household cats were more susceptible than dogs to natural infection…
As the first trial of its kind, researchers will use common and widely available drugs to treat symptoms of COVID-19. This story was…